cerebyx
Generic: fosphenytoin sodium
Labeler: pfizer laboratories div pfizer incDrug Facts
Product Profile
Brand Name
cerebyx
Generic Name
fosphenytoin sodium
Labeler
pfizer laboratories div pfizer inc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
fosphenytoin sodium 50 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0069-6001
Product ID
0069-6001_c2767f24-e5ac-4d94-8bff-faf0a6eaf7c4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA020450
Listing Expiration
2026-12-31
Marketing Start
2013-10-28
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00696001
Hyphenated Format
0069-6001
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cerebyx (source: ndc)
Generic Name
fosphenytoin sodium (source: ndc)
Application Number
NDA020450 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/mL
Packaging
- 10 VIAL in 1 PACKAGE (0069-6001-21) / 10 mL in 1 VIAL (0069-6001-10)
- 25 VIAL in 1 CARTON (0069-6001-25) / 2 mL in 1 VIAL (0069-6001-02)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "c2767f24-e5ac-4d94-8bff-faf0a6eaf7c4", "openfda": {"unii": ["7VLR55452Z"], "rxcui": ["1670195", "1670197", "1670200", "1670201"], "spl_set_id": ["d4c36fad-0ba2-4cd4-9c5e-dcf843f38a5a"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 PACKAGE (0069-6001-21) / 10 mL in 1 VIAL (0069-6001-10)", "package_ndc": "0069-6001-21", "marketing_start_date": "20131028"}, {"sample": false, "description": "25 VIAL in 1 CARTON (0069-6001-25) / 2 mL in 1 VIAL (0069-6001-02)", "package_ndc": "0069-6001-25", "marketing_start_date": "20131028"}], "brand_name": "CEREBYX", "product_id": "0069-6001_c2767f24-e5ac-4d94-8bff-faf0a6eaf7c4", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0069-6001", "generic_name": "Fosphenytoin Sodium", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CEREBYX", "active_ingredients": [{"name": "FOSPHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "NDA020450", "marketing_category": "NDA", "marketing_start_date": "20131028", "listing_expiration_date": "20261231"}